These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9755908)

  • 1. Effect of neutral endopeptidase inhibition on the natriuresis and renal clearance of atrial natriuretic peptide in perfused rat kidney.
    Yamaguchi M; Hashimoto Y; Itoh H; Nakao K; Inui K
    Pharm Res; 1998 Sep; 15(9):1499-502. PubMed ID: 9755908
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
    Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides.
    Ozaki J; Shimizu H; Hashimoto Y; Itoh H; Nakao K; Inui K
    Eur J Pharmacol; 1999 Apr; 370(3):307-12. PubMed ID: 10334507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
    Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
    Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic peptide-potentiating actions of neutral endopeptidase inhibition in rats with experimental heart failure.
    Yasuhara M; Yamaguchi M; Shimizu H; Hashimoto Y; Hama N; Itoh H; Nakao K; Hori R
    Pharm Res; 1994 Dec; 11(12):1726-30. PubMed ID: 7899235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Fennell SA; Cheung HS; Rogers WL
    Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endopeptidase-24.11 and its inhibitors: potential therapeutic agents for edematous disorders and hypertension.
    Wilkins MR; Unwin RJ; Kenny AJ
    Kidney Int; 1993 Feb; 43(2):273-85. PubMed ID: 8441223
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat.
    Kirk JE; Wilkins MR
    Br J Pharmacol; 1993 Sep; 110(1):350-4. PubMed ID: 8220896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor.
    Kanazawa M; Casley DJ; Sybertz EJ; Haslanger MF; Johnston CI
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1231-7. PubMed ID: 1534841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ANP clearance receptors and endopeptidase 24.11 in maturing rats.
    Chevalier RL; Garmey M; Scarborough RM; Linden J; Gomez RA; Peach MJ; Carey RM
    Am J Physiol; 1991 Jun; 260(6 Pt 2):R1218-28. PubMed ID: 1647702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neutral endopeptidase (EC 3.4.24.11) leads to an atrial natriuretic factor-mediated natriuretic, diuretic and antihypertensive response in rodents.
    Shepperson NB; Barclay PL; Bennett JA; Samuels GM
    Clin Sci (Lond); 1991 Mar; 80(3):265-9. PubMed ID: 1850687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade.
    Barclay PL; Bennett JA; Greengrass PM; Griffin A; Samuels GM; Shepperson NB
    Biochem Pharmacol; 1992 Sep; 44(6):1013-22. PubMed ID: 1417928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of atrial natriuretic peptide after bolus and infusion administration in the isolated perfused rat kidney.
    Brier ME; Harding GB
    J Pharmacol Exp Ther; 1989 May; 249(2):372-7. PubMed ID: 2542527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphonamide inhibitors of neutral endopeptidase (EC 3.4.24.11).
    Norcini G; Morazzoni G; Pocchiari F; Santangelo F; Semeraro C
    J Enzyme Inhib; 1997 Apr; 12(1):71-7. PubMed ID: 9204384
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetics and pharmacodynamics of atrial natriuretic peptide and lithium clearance in the isolated perfused rat kidney.
    Brier ME; Brier RA; Luft FC; Aronoff GR
    J Pharmacol Exp Ther; 1987 Dec; 243(3):868-73. PubMed ID: 2961879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men.
    Regamey F; Maillard M; Nussberger J; Brunner HR; Burnier M
    Hypertension; 2002 Sep; 40(3):266-72. PubMed ID: 12215465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance mechanisms of atrial and brain natriuretic peptides in rats.
    Hashimoto Y; Nakao K; Hama N; Imura H; Mori S; Yamaguchi M; Yasuhara M; Hori R
    Pharm Res; 1994 Jan; 11(1):60-4. PubMed ID: 8140057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition.
    Abassi ZA; Tate J; Hunsberger S; Klein H; Trachewsky D; Keiser HR
    Am J Physiol; 1992 Nov; 263(5 Pt 1):E870-6. PubMed ID: 1443119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.